Access Resources
5751 - 5800 of 7616 Results
Title
Year
- Feasibility and Safety of Multisite Tissue and Biofluid Sampling for Synuclein in Parkinson’s Disease: The Systemic Synuclein Sampling Study (S4) (P1.013)2017RESTRICTEDTitle: Feasibility and Safety of Multisite Tissue and Biofluid Sampling for Synuclein in Parkinson’s Disease: The Systemic Synuclein Sampling Study (S4) (P1.013)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 88Issue #: 16_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.88.16_supplement.p1.013Citation Count: 0
-
-
RESTRICTEDTitle: Fox Insight: a Large-Scale Web-Enabled Parkinson’s Disease Study (P4.007)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 88Issue #: 16_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.88.16_supplement.p4.007Citation Count: 0
- Genetic analysis of α‐synuclein 3′ untranslated region and its corresponding microRNAs in relation to Parkinson's disease compared to dementia with Lewy bodies2017RESTRICTEDTitle: Genetic analysis of α‐synuclein 3′ untranslated region and its corresponding microRNAs in relation to Parkinson's disease compared to dementia with Lewy bodiesJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 13Issue #: 11Start Page: 1237End Page: 1250Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jalz.2017.03.001Best OA location URL: https://europepmc.org/articles/pmc5647200?pdf=renderCitation Count: 25
-
RESTRICTEDTitle: Neuropathic Gaucher’s Mutations: Shifting Parkinson’s Into High Gear (S1.002)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 88Issue #: 16_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.88.16_supplement.s1.002Citation Count: 0
-
RESTRICTEDTitle: Targeted deletion of GD3 synthase protects against MPTP‐induced neurodegenerationJournal Name: Genes, Brain and BehaviorPublisher: WileyVol: 16Issue #: 5Start Page: 522End Page: 536Publication Date:Open Access(OA) Status: RESTRICTEDLicense: public-domainDOI - Digital Object Identifier: 10.1111/gbb.12377Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/gbb.12377Citation Count: 18
-
RESTRICTEDTitle: Nonsinusoidal Beta Oscillations Reflect Cortical Pathophysiology in Parkinson's DiseaseJournal Name: The Journal of NeurosciencePublisher: Society for NeuroscienceVol: 37Issue #: 18Start Page: 4830End Page: 4840Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-saDOI - Digital Object Identifier: 10.1523/jneurosci.2208-16.2017Best OA location URL: https://www.jneurosci.org/content/jneuro/37/18/4830.full.pdfCitation Count: 185
- DaT-SPECT assessment depicts dopamine depletion among asymptomatic G2019S LRRK2 mutation carriers2017RESTRICTEDTitle: DaT-SPECT assessment depicts dopamine depletion among asymptomatic G2019S LRRK2 mutation carriersJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 12Issue #: 4Start Page: e0175424End Page: e0175424Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0175424Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0175424&type=printableCitation Count: 27
-
RESTRICTEDTitle: Ubiquitin and Parkinson's disease through the looking glass of geneticsJournal Name: Biochemical JournalPublisher: Portland Press Ltd.Vol: 474Issue #: 9Start Page: 1439End Page: 1451Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1042/bcj20160498Best OA location URL: https://portlandpress.com/biochemj/article-pdf/474/9/1439/689414/bcj-2016-0498c.pdfCitation Count: 53
-
RESTRICTEDTitle: Integrated molecular landscape of Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 3Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-017-0015-3Best OA location URL: https://www.nature.com/articles/s41531-017-0015-3.pdfCitation Count: 96
- Increased brain expression of GPNMB is associated with genome wide significant risk for Parkinson’s disease on chromosome 7p15.32017RESTRICTEDTitle: Increased brain expression of GPNMB is associated with genome wide significant risk for Parkinson’s disease on chromosome 7p15.3Journal Name: neurogeneticsPublisher: Springer Science and Business Media LLCVol: 18Issue #: 3Start Page: 121End Page: 133Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1007/s10048-017-0514-8Best OA location URL: https://link.springer.com/content/pdf/10.1007%2Fs10048-017-0514-8.pdfCitation Count: 58
-
RESTRICTEDTitle: Media hype: Patient and scientific perspectives on misleading medical newsJournal Name: Movement DisordersPublisher: WileyVol: 32Issue #: 9Start Page: 1319End Page: 1323Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26993Citation Count: 38
- The Unfolded Protein Response: At the Intersection between Endoplasmic Reticulum Function and Mitochondrial Bioenergetics2017RESTRICTEDTitle: The Unfolded Protein Response: At the Intersection between Endoplasmic Reticulum Function and Mitochondrial BioenergeticsJournal Name: Frontiers in OncologyPublisher: Frontiers Media SAVol: 7Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fonc.2017.00055Best OA location URL: https://www.frontiersin.org/articles/10.3389/fonc.2017.00055/pdfCitation Count: 37
- A randomized trial of relamorelin for constipation in Parkinson's disease (MOVE-PD): Trial results and lessons learned2017RESTRICTEDTitle: A randomized trial of relamorelin for constipation in Parkinson's disease (MOVE-PD): Trial results and lessons learnedJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 37Issue #:Start Page: 101End Page: 105Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2017.02.003Citation Count: 31
-
RESTRICTEDTitle: An Anatomically Resolved Mouse Brain Proteome Reveals Parkinson Disease-relevant PathwaysJournal Name: Molecular & Cellular ProteomicsPublisher: Elsevier BVVol: 16Issue #: 4Start Page: 581End Page: 593Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1074/mcp.m116.061440Best OA location URL: https://www.mcponline.org/content/mcprot/16/4/581.full.pdfCitation Count: 52
- Chelerythrine promotes Ca2+-dependent calpain activation in neuronal cells in a PKC-independent manner2017RESTRICTEDTitle: Chelerythrine promotes Ca2+-dependent calpain activation in neuronal cells in a PKC-independent mannerJournal Name: Biochimica et Biophysica Acta (BBA) - General SubjectsPublisher: Elsevier BVVol: 1861Issue #: 4Start Page: 922End Page: 935Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.bbagen.2017.01.021Citation Count: 12
- Differential Aging Analysis in Human Cerebral Cortex Identifies Variants in TMEM106B and GRN that Regulate Aging Phenotypes2017RESTRICTEDTitle: Differential Aging Analysis in Human Cerebral Cortex Identifies Variants in TMEM106B and GRN that Regulate Aging PhenotypesJournal Name: Cell SystemsPublisher: Elsevier BVVol: 4Issue #: 4Start Page: 404End Page: 415.e5Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.cels.2017.02.009Best OA location URL: http://www.cell.com/article/S2405471217300534/pdfCitation Count: 95
- Methamphetamine‐induced mitochondrial oxidant stress mediated by monoamine oxidase metabolism of dopamine2017RESTRICTEDTitle: Methamphetamine‐induced mitochondrial oxidant stress mediated by monoamine oxidase metabolism of dopamineJournal Name: The FASEB JournalPublisher: WileyVol: 31Issue #: S1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1096/fasebj.31.1_supplement.987.3Best OA location URL: https://doi.org/10.1096/fasebj.31.1_supplement.987.3Citation Count: 0
-
RESTRICTEDTitle: Probabilistic conversion of neurosurgical DBS electrode coordinates into MNI spaceJournal Name: NeuroImagePublisher: Elsevier BVVol: 150Issue #:Start Page: 395End Page: 404Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuroimage.2017.02.004Best OA location URL: https://europepmc.org/articles/pmc6050588?pdf=renderCitation Count: 118
- Thalamic cholinergic innervation makes a specific bottom-up contribution to signal detection: Evidence from Parkinson’s disease patients with defined cholinergic losses2017RESTRICTEDTitle: Thalamic cholinergic innervation makes a specific bottom-up contribution to signal detection: Evidence from Parkinson’s disease patients with defined cholinergic lossesJournal Name: NeuroImagePublisher: Elsevier BVVol: 149Issue #:Start Page: 295End Page: 304Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuroimage.2017.02.006Best OA location URL: https://europepmc.org/articles/pmc5386784?pdf=renderCitation Count: 33
-
RESTRICTEDTitle: The Systemic Synuclein Sampling Study: toward a biomarker for Parkinson's diseaseJournal Name: Biomarkers in MedicinePublisher: Informa UK LimitedVol: 11Issue #: 4Start Page: 359End Page: 368Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.2217/bmm-2016-0366Best OA location URL: https://www.futuremedicine.com/doi/pdf/10.2217/bmm-2016-0366Citation Count: 47
- Disentangling the neural correlates of corticobasal syndrome and corticobasal degeneration with systematic and quantitative ALE meta-analyses2017RESTRICTEDTitle: Disentangling the neural correlates of corticobasal syndrome and corticobasal degeneration with systematic and quantitative ALE meta-analysesJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 3Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-017-0012-6Best OA location URL: https://www.nature.com/articles/s41531-017-0012-6.pdfCitation Count: 29
- Cerebrospinal fluid levels of catecholamines and its metabolites in Parkinson's disease: effect of l‐DOPA treatment and changes in levodopa‐induced dyskinesia2017RESTRICTEDTitle: Cerebrospinal fluid levels of catecholamines and its metabolites in Parkinson's disease: effect of l‐DOPA treatment and changes in levodopa‐induced dyskinesiaJournal Name: Journal of NeurochemistryPublisher: WileyVol: 141Issue #: 4Start Page: 614End Page: 625Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/jnc.13997Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jnc.13997Citation Count: 32
- Trial of dextromethorphan/quinidine to treat levodopa-induced dyskinesia in Parkinson's disease2017RESTRICTEDTitle: Trial of dextromethorphan/quinidine to treat levodopa-induced dyskinesia in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 32Issue #: 6Start Page: 893End Page: 903Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26976Citation Count: 29
- Kinetin Riboside and Its ProTides Activate the Parkinson’s Disease Associated PTEN-Induced Putative Kinase 1 (PINK1) Independent of Mitochondrial Depolarization2017RESTRICTEDTitle: Kinetin Riboside and Its ProTides Activate the Parkinson’s Disease Associated PTEN-Induced Putative Kinase 1 (PINK1) Independent of Mitochondrial DepolarizationJournal Name: Journal of Medicinal ChemistryPublisher: American Chemical Society (ACS)Vol: 60Issue #: 8Start Page: 3518End Page: 3524Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1021/acs.jmedchem.6b01897Best OA location URL: https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.6b01897Citation Count: 70
-
RESTRICTEDTitle: LRRK2 levels in immune cells are increased in Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 3Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-017-0010-8Best OA location URL: https://doi.org/10.1038/s41531-017-0010-8Citation Count: 178
- The prodromal phase of leucine‐rich repeat kinase 2–associated Parkinson disease: Clinical and imaging Studies2017RESTRICTEDTitle: The prodromal phase of leucine‐rich repeat kinase 2–associated Parkinson disease: Clinical and imaging StudiesJournal Name: Movement DisordersPublisher: WileyVol: 32Issue #: 5Start Page: 726End Page: 738Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26964Citation Count: 49
-
RESTRICTEDTitle: Nurr1:RXRα heterodimer activation as monotherapy for Parkinson’s diseaseJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 114Issue #: 15Start Page: 3999End Page: 4004Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1073/pnas.1616874114Best OA location URL: https://www.pnas.org/content/pnas/114/15/3999.full.pdfCitation Count: 62
-
RESTRICTEDTitle: Cortical surface‐based threshold‐free cluster enhancement and cortexwise mediationJournal Name: Human Brain MappingPublisher: WileyVol: 38Issue #: 6Start Page: 2795End Page: 2807Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/hbm.23563Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hbm.23563Citation Count: 19
-
RESTRICTEDTitle: Epidemiology, Diagnosis, and Management of Neurogenic Orthostatic HypotensionJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 4Issue #: 3Start Page: 298End Page: 308Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12478Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12478Citation Count: 61
- Photobiomodulation-induced changes in a monkey model of Parkinson’s disease: changes in tyrosine hydroxylase cells and GDNF expression in the striatum2017RESTRICTEDTitle: Photobiomodulation-induced changes in a monkey model of Parkinson’s disease: changes in tyrosine hydroxylase cells and GDNF expression in the striatumJournal Name: Experimental Brain ResearchPublisher: Springer Science and Business Media LLCVol: 235Issue #: 6Start Page: 1861End Page: 1874Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00221-017-4937-0Citation Count: 41
- Your algorithm might think the hippocampus grows in Alzheimer's disease: Caveats of longitudinal automated hippocampal volumetry2017RESTRICTEDTitle: Your algorithm might think the hippocampus grows in Alzheimer's disease: Caveats of longitudinal automated hippocampal volumetryJournal Name: Human Brain MappingPublisher: WileyVol: 38Issue #: 6Start Page: 2875End Page: 2896Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/hbm.23559Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hbm.23559Citation Count: 22
- Age-dependent dopamine transporter dysfunction and Serine129 phospho-α-synuclein overload in G2019S LRRK2 mice2017RESTRICTEDTitle: Age-dependent dopamine transporter dysfunction and Serine129 phospho-α-synuclein overload in G2019S LRRK2 miceJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 5Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40478-017-0426-8Best OA location URL: https://actaneurocomms.biomedcentral.com/track/pdf/10.1186/s40478-017-0426-8Citation Count: 72
-
RESTRICTEDTitle: Protein misfolding in neurodegenerative diseases: implications and strategiesJournal Name: Translational NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 6Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40035-017-0077-5Best OA location URL: https://translationalneurodegeneration.biomedcentral.com/track/pdf/10.1186/s40035-017-0077-5Citation Count: 420
-
RESTRICTEDTitle: Structure-guided mutagenesis reveals a hierarchical mechanism of Parkin activationJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1038/ncomms14697Best OA location URL: https://www.nature.com/articles/ncomms14697.pdfCitation Count: 76
- Disease-Specific Regions Outperform Whole-Brain Approaches in Identifying Progressive Supranuclear Palsy: A Multicentric MRI Study2017RESTRICTEDTitle: Disease-Specific Regions Outperform Whole-Brain Approaches in Identifying Progressive Supranuclear Palsy: A Multicentric MRI StudyJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 11Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2017.00100Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2017.00100/pdfCitation Count: 10
- Subcortical Shape Changes, Hippocampal Atrophy and Cortical Thinning in Future Alzheimer's Disease Patients2017RESTRICTEDTitle: Subcortical Shape Changes, Hippocampal Atrophy and Cortical Thinning in Future Alzheimer's Disease PatientsJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 9Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2017.00038Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2017.00038/pdfCitation Count: 46
- Neuropathological Staging of Brain Pathology in Sporadic Parkinson’s disease: Separating the Wheat from the Chaff2017RESTRICTEDTitle: Neuropathological Staging of Brain Pathology in Sporadic Parkinson’s disease: Separating the Wheat from the ChaffJournal Name: Journal of Parkinson's DiseasePublisher: IOS PressVol: 7Issue #: s1Start Page: S71End Page: S85Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-179001Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd179001?id=journal-of-parkinsons-disease%2Fjpd179001Citation Count: 262
-
RESTRICTEDTitle: The Identification of Alpha-Synuclein as the First Parkinson Disease GeneJournal Name: Journal of Parkinson's DiseasePublisher: IOS PressVol: 7Issue #: s1Start Page: S43End Page: S49Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-179003Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd179003?id=journal-of-parkinsons-disease%2Fjpd179003Citation Count: 55
-
RESTRICTEDTitle: Diagnosing the frontal variant of Alzheimer’s disease: a clinician’s yellow brick roadJournal Name: Journal of Clinical Movement DisordersPublisher: Springer Science and Business Media LLCVol: 4Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40734-017-0052-4Best OA location URL: https://clinicalmovementdisorders.biomedcentral.com/track/pdf/10.1186/s40734-017-0052-4Citation Count: 26
-
RESTRICTEDTitle: Consensus classification of posterior cortical atrophyJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 13Issue #: 8Start Page: 870End Page: 884Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.jalz.2017.01.014Best OA location URL: http://www.alzheimersanddementia.com/article/S1552526017300407/pdfCitation Count: 432
- Freezing of gait and fall detection in Parkinson’s disease using wearable sensors: a systematic review2017RESTRICTEDTitle: Freezing of gait and fall detection in Parkinson’s disease using wearable sensors: a systematic reviewJournal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 264Issue #: 8Start Page: 1642End Page: 1654Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00415-017-8424-0Best OA location URL: https://link.springer.com/content/pdf/10.1007%2Fs00415-017-8424-0.pdfCitation Count: 141
-
RESTRICTEDTitle: Indirect tolerability comparison of Deutetrabenazine and Tetrabenazine for Huntington diseaseJournal Name: Journal of Clinical Movement DisordersPublisher: Springer Science and Business Media LLCVol: 4Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40734-017-0051-5Best OA location URL: https://clinicalmovementdisorders.biomedcentral.com/track/pdf/10.1186/s40734-017-0051-5Citation Count: 69
-
RESTRICTEDTitle: Loss of α-Synuclein Does Not Affect Mitochondrial Bioenergetics in Rodent NeuronsJournal Name: eneuroPublisher: Society for NeuroscienceVol: 4Issue #: 2Start Page: ENEURO.0216End Page: 16.2017Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-saDOI - Digital Object Identifier: 10.1523/eneuro.0216-16.2017Best OA location URL: https://www.eneuro.org/content/eneuro/4/2/ENEURO.0216-16.2017.full.pdfCitation Count: 15
- Nanoparticle standards for immuno-based quantitation of α-synuclein oligomers in diagnostics of Parkinson's disease and other synucleinopathies2017RESTRICTEDTitle: Nanoparticle standards for immuno-based quantitation of α-synuclein oligomers in diagnostics of Parkinson's disease and other synucleinopathiesJournal Name: Clinica Chimica ActaPublisher: Elsevier BVVol: 466Issue #:Start Page: 152End Page: 159Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.cca.2017.01.010Citation Count: 20
-
RESTRICTEDTitle: Neuropsychiatric symptoms in untreated Parkinson’s diseaseJournal Name: Neuropsychiatric Disease and TreatmentPublisher: Informa UK LimitedVol: Volume 13Issue #:Start Page: 815End Page: 826Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.2147/ndt.s130997Best OA location URL: https://www.dovepress.com/getfile.php?fileID=35506Citation Count: 39
- Genome-wide association study identifies four novel loci associated with Alzheimer’s endophenotypes and disease modifiers2017RESTRICTEDTitle: Genome-wide association study identifies four novel loci associated with Alzheimer’s endophenotypes and disease modifiersJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 133Issue #: 5Start Page: 839End Page: 856Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00401-017-1685-yBest OA location URL: https://europepmc.org/articles/pmc5613285?pdf=renderCitation Count: 186
-
RESTRICTEDTitle: In vivo detection of lateral–ventral tier nigral degeneration in Parkinson's diseaseJournal Name: Human Brain MappingPublisher: WileyVol: 38Issue #: 5Start Page: 2627End Page: 2634Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/hbm.23547Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hbm.23547Citation Count: 48
- Biomarker‐driven phenotyping in Parkinson's disease: A translational missing link in disease‐modifying clinical trials2017RESTRICTEDTitle: Biomarker‐driven phenotyping in Parkinson's disease: A translational missing link in disease‐modifying clinical trialsJournal Name: Movement DisordersPublisher: WileyVol: 32Issue #: 3Start Page: 319End Page: 324Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26913Best OA location URL: https://ri.conicet.gov.ar/bitstream/11336/40514/5/CONICET_Digital_Nro.82df6a72-6ca0-4e97-82ab-71e013c4c8bf_s.pdfCitation Count: 145
-
RESTRICTEDTitle: Engineering Iron Responses in Mammalian Cells by Signal-Induced Protein ProximityJournal Name: ACS Synthetic BiologyPublisher: American Chemical Society (ACS)Vol: 6Issue #: 6Start Page: 921End Page: 927Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acssynbio.6b00255Citation Count: 12